Rivulet Media Inc (fka RIVU)

[Canadian Trader]

SUMMARY OF HEMAXELLERATE I PROGRESS:

Jan 24, 2013 - Pre-clinical proof of concept and plan to file IND.
http://ih.advfn.com/p.php?pid=nmona&article=55986712

Feb 5, 2013 - Announcement that IND was filed.
http://ih.advfn.com/p.php?pid=nmona&article=56150687

Mar 18, 2013 - Regen receives IND# from FDA.
http://ih.advfn.com/p.php?pid=nmona&article=56788567

Apr 4, 2013 - FDA will send a letter outlining items which must be addressed prior to initiating clinical trials.
http://ih.advfn.com/p.php?pid=nmona&article=57035344

Jun 6, 2013 - Regen responds to FDA questions (including new data).
http://ih.advfn.com/p.php?pid=nmona&article=57897013

Jul 31, 2013 - Regen in second round of discussion with FDA on a new set of FDA comments.
http://ih.advfn.com/p.php?pid=nmona&article=58628844

Sept 26, 2013 - Agreement for pre-clinical animal trials with WP Min to address FDA comments.
http://ih.advfn.com/p.php?pid=nmona&article=59372541

Oct 31, 2013 - Cook General Biotechnology to continue producing clinical grade HemaXellerate I for pre-clinial and clinical studies.
http://ih.advfn.com/p.php?pid=nmona&article=59847939

Dec 11, 2013 - Update on WP Min work regarding pre-clinical animal studies
http://ih.advfn.com/p.php?pid=nmona&article=60352616

May 12, 2014 - FDA accepted the clinical protocol and the product manufacturing information; clarification on animal safety studies was requested.
http://ih.advfn.com/p.php?pid=nmona&article=62167863

** All dates listed above refer to the date of the linked PR **

The point of this exercise was to demonstrate that it is easy to have criticism of any single PR. However, when you look at the progression of HemaXellerate over its (so far) 1.5 year publicized story, there is an undeniable progression that shows how this group is constantly moving towards FDA approval and covering all their bases along the way. Considering how critical these review processes can be, it is impressive to see them at this stage in such a short time. Patience will pay off here.

$$ BMSN / Regen BioPharma $$